Cargando…
Residues remote from the binding pocket control the antagonist selectivity towards the corticotropin-releasing factor receptor-1
The corticotropin releasing factors receptor-1 and receptor-2 (CRF(1)R and CRF(2)R) are therapeutic targets for treating neurological diseases. Antagonists targeting CRF(1)R have been developed for the potential treatment of anxiety disorders and alcohol addiction. It has been found that antagonists...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308710/ https://www.ncbi.nlm.nih.gov/pubmed/25628267 http://dx.doi.org/10.1038/srep08066 |